Graypoint LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$101K Buy
+10,469
New +$108K 0.01% 523
2025
Q1
Sell
-10,467
Closed -$156K 526
2024
Q4
$156K Sell
10,467
-4,088
-28% -$66.6K 0.01% 508
2024
Q3
$278K Buy
14,555
+853
+6% +$17.7K 0.02% 413
2024
Q2
$284K Buy
13,702
+996
+8% +$19.8K 0.02% 394
2024
Q1
$240K Buy
12,706
+2,608
+26% +$44.8K 0.02% 410
2023
Q4
$148K Buy
+10,098
New +$137K 0.01% 426

Other funds holding OGN

Graypoint LLC's OGN Position: Q2 2025 in Review

Graypoint LLC opened a new position in Organon & Co (OGN) in Q2 2025: 10,469 shares worth $101K. The stake represents 0.01% of the portfolio and ranks #523 among its holdings. This is a return to the name: Graypoint LLC previously reported a position in OGN as recently as Q4 2024.

Graypoint LLC first reported a position in OGN in Q4 2023 and has held it in 6 quarters since. The position peaked at $284K in Q2 2024. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Graypoint LLC held 10,469 shares of Organon & Co worth $101K as of Q2 2025.
  • Organon & Co was a new Graypoint LLC position in Q2 2025.
  • Organon & Co made up 0.01% of Graypoint LLC's portfolio in Q2 2025, its #523 holding.
  • Graypoint LLC first reported a position in Organon & Co in Q4 2023 and has held it in 6 quarters since.
  • Graypoint LLC's Organon & Co position peaked at $284K in Q2 2024.
  • 694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.